The 47th Annual Ishmael Rheumatology Symposium and Inaugural Morris Reichlin Memorial Lectureship, 22003

Friday, October 1, 2021, 7:30 AM - 5:00 PM, Zoom Videoconference, Oklahoma City, OK


This intensive one day offering that includes a review and update on major subject areas in rheumatology. The faculty chosen to speak are recruited locally and from nationally recognized leaders in their fields.  The topics are chosen from the prior years participant suggestions.  The seminars are focused on practical diagnosis, treatment, and latest research in areas related to the successful delivery of rheumatology health care and patient outcomes. The University of Oklahoma College of Medicine faculty is nationally recognized for their expertise in the management of complex conditions that is unavailable elsewhere in the state, region or sometimes even the nation. This is a very fast-paced symposium with five lectures and one small group meeting.  Each session will include time for questions and answers. The course combines best practice strategies and education through case studies and lectures.

1. Discuss if people receiving immunosuppressive drugs more susceptible to initial infection with SARS-CoV-2.
2. Describe the outcomes of COVID-19 in immunosuppressed individuals.
3. Identify the rheumatology drugs that are effective for treating COVID-19
4. Describe antibody response in our rheumatic patients.
5. Describe lupus nephritis screening and surveillance guidelines.
6. Identify lupus nephritis treatment guidelines.
7. Compare new lupus nephritis treatments.
8. Describe myositis specific auto-antibodies that define disease complications and predict response to therapies.
9. Describe how pregnancy outcomes in lupus data was assessed and interpreted.
10. Demonstrate how to implement pregnancy guidelines in the clinical care of patients.
11. Estimate risks of medication use during lupus pregnancies with risks of under treated disease.
12. Summarize the temporal changes in pregnancy outcomes in SLE as management paradigms have evolved.

1. Discuss if people receiving immunosuppressive drugs more susceptible to initial infection with SARS-CoV-2.
2. Describe the outcomes of COVID-19 in immunosuppressed individuals.
3. Identify the rheumatology drugs that are effective for treating COVID-19.
4. Describe antibody response in our rheumatic patients.
5. Describe lupus nephritis screening and surveillance guidelines.
6. Identify lupus nephritis treatment guidelines.
7. Compare new lupus nephritis treatments.
8. Describe myositis specific auto-antibodies that define disease complications and predict response to therapies.
9. Describe how pregnancy outcomes in lupus data was assessed and interpreted.
10. Demonstrate how to implement pregnancy guidelines in the clinical care of patients.
11. Estimate risks of medication use during lupus pregnancies with risks of under treated disease.
12. Summarize the temporal changes in pregnancy outcomes in SLE as management paradigms have evolved.

Early Bird Registration (by 9/27/2021):

Virtual Registration Fees:
Physician (MD, DO) Virtual, Early Rate - $100.00
Other Healthcare Providers ( PA, Nurses, PharmD, etc.) Virtual, Early Rate - $100.00

OUHSC Fellows, Virtual, Early Rate - $100.00 ***
OUHSC Residents, Medical Students, Virtual, Early Rate - $100.00 *** 
OUHSC Rheumatology Faculty, Virtual, Early Rate - $100.00 ***
VA Rheumatology PAs, Virtual, Early Rate - $100.00 ***

*** Please contact Nicole L. Lung for promo code before registering. (405-271-2330 / [email protected])

Regular Registration (9/28/2021):

Virtual Registration Fees:
Physician (MD, DO) Virtual, Regular Rate - $125.00
Other Healthcare Providers ( PA, Nurses, PharmD, etc.) Virtual, Regular Rate - $125.00

OUHSC Fellows, Virtual, Regular Rate - $125.00 ***
OUHSC Residents, Medical Students, Virtual, Regular Rate - $125.00 *** 
OUHSC Rheumatology Faculty, Virtual, Regular Rate - $125.00 ***
VA Rheumatology PAs, Virtual, Regular Rate - $125.00 ***

*** Please contact Nicole L. Lung for promo code before registering. (405-271-2330 / [email protected])



Registration Notes:
• Registration Fee for Virtual attendance includes course materials and CME credit.

• No registration refunds will be made after September 20, 2021.
• Written notification of cancellation must be postmarked before September 20, 2021.
• Cancellation fee is $25.
• Confirmations will be emailed. (This annual conference is subject to cancellation if registration is insufficient, in which case all registration fees will be refunded.)

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Accreditation Statement: 
OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

CNE Disclosure Statements: 
OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

6.00 CNE contact hours will be awarded for meeting the following criteria: 90% attendance of conference, completion and submission of evaluation form.

This educational activity does not include any content that relates to the products and/or services of a commercial interest that would create a conflict of interest.

 

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Within 60 days of the end of the session, ABIM MOC Points will be reported on your behalf.

For information about ACCME accreditation and ABIM MOC for this session, please email myrna [email protected]

By providing your ABIM number, you consent to have the OUHSC CPD Office submit your participation in this activity to the ABIM through the ACCME PARS system.

Learning Format: Live Virtual Activity

AAFP Accreditation Statement: 
The AAFP has reviewed The 47th Annual Ishmael Rheumatology Symposium and Inaugural Morris Reichlin Memorial Lectureship and deemed it acceptable for up to 6.00 In-Person, Live (could include online) AAFP Elective credit. Term of Approval is from 10/01/2021 to 10/01/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Accreditation Statement:
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 6 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 10/1/2021 to 10/1/2021. AAPA reference number: CME-203447.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides. Inquiries regarding non-discrimination policies may be directed to: Shaniqua Crawford, JD, Institutional Equity Officer and Title IX Coordinator, 405-325-3546, [email protected], or visit www.ou.edu/eoo.html. 

Accommodation Statement:
Accommodations on the basis of disability are available Nicole L. Lung at (405) 408-3198 or [email protected] by contacting as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also disclose discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s). 

AMA PRA Category 1 Credits™ (6.00 hours), Non-Physician Attendance (6.00 hours), American Academy of Family Phy Elective Credits (6.00 hours), AAPA Category 1 CME Credit (6.00 hours), ANCC Nursing Contact Hours (6.00 hours), ABIM MOC Part 2 (5.00 hours)

The 47th Annual Ishmael Rheumatology Symposium and Inaugural Morris Reichlin Memorial Lectureship Planning Committee Members:

Mary Beth Humphrey, MD, PhD – Course Director
Nicole L. Lung, MS – Course Contact
Rabia S. Cheema, MD 
Carol L. Davenport, MSN, RN-BC, NPD-BC
Matlock A. Jeffries, MD, FACP, FACR
Aikaterina (Katherine) Thanou, MD
Angie R. Thomas, PA-C
Samera Vaseer, MD

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s planner and presenter disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable. 

Friday, October 1, 2021

Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.